POLD1 and cancer: We first analyze the molecular mechanisms by which domain-specific POLD1 mutations—whether in the exonuclease, polymerase, or regulatory regions—drive genomic instability and fuel cancer progression across diverse clinical contexts, from PPAP to sporadic malignancies.